Recent work has implicated several signaling molecules that are known to be involved in the control of cell growth, differentiation, and apoptosis related to the regulation of Th2 differentiation and function. However, key questions concerning the interactions among these different signaling pathways and their relative importance in vivo remain unanswered. This proposal is based on our previous studies of atypical PKCs and p62 signaling pathways involved in Th2 differentiation. The Th2 polarization system is not only important from the point of view of asthma and other allergic diseases, but is also a very interesting paradigm of cell differentiation in which the crosstalk between different signaling pathways, including NF-?B and the Jak1/Stat6 cascade, are set in motion to ensure the efficiency and selectivity of the polarization pathways. Aberrations in Th2 differentiation lead to asthma, a chronic lung condition involving inflammation of the airways. Epidemiological studies demonstrate that there has been a worldwide increase in the prevalence of asthma since 1980, and that this disease affects about 15 million people in the US, of which 5 million are children. The long-term goal of the studies proposed here is to unravel the signaling cascades involved in Th2 differentiation, which will be critical in the control of allergic diseases, especially asthma. The overall objective of this proposal is to test the hypothesis that p62 and the aPKCs are essential players in these processes. Specifically, we will determine the role and mechanism of action of p62 in Th2 function, focusing on the pathways whereby p62 regulates the sustained phase of NF-?B activation during Th2 differentiation, as well as the potential role of PKC ?/??in this cascade. This will be addressed using mice with a "floxed" PKC ?/??gene, and in studies using p62- and PKC?-deficient mice and cells. Additionally, we will carry out studies to understand at a mechanistic level how PKC?, and potentially also PKC ?/? regulate Jak1 in the IL-4/Stat6 cascade. All the results from these ex vivo and in vitro studies will be validated in in vivo systems where we will assess the relevance of these molecules to asthma in a mouse model of allergic airway inflammation. This study will increase our understanding of the different mechanisms involved in the regulation of Th2 differentiation and asthma, and could also contribute to the development of novel and less toxic therapies for allergic pulmonary inflammation. Public Health Relevance Statement: Asthma is a chronic lung condition involving inflammation of the airways. It affects about 15 million people in the US, of which 5 million are children, and is considered to be the most common reason for childhood hospitalizations and school absenteeism. Epidemiological studies demonstrate that since 1980 there has been a worldwide increase in the prevalence of asthma. The pathology of asthma and other allergic diseases is associated with aberrant activation of CD4+ Th2 cells. Recent work has implicated several signaling molecules that are known to be involved in the control of cell growth, differentiation, and apoptosis in the regulation of Th2 differentiation and function. However, key questions concerning the interactions among these different signaling pathways and their relative importance in vivo remain unanswered. This study will increase our understanding of the different mechanisms involved in the regulation of Th2 differentiation and asthma, and would also contribute to the development of novel and less toxic therapies for allergic pulmonary inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI072581-05
Application #
8223196
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Davidson, Wendy F
Project Start
2008-01-15
Project End
2013-12-31
Budget Start
2012-01-01
Budget End
2013-12-31
Support Year
5
Fiscal Year
2012
Total Cost
$467,998
Indirect Cost
$222,973
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kim, Ji Young; Valencia, Tania; Abu-Baker, Shadi et al. (2013) c-Myc phosphorylation by PKCýý represses prostate tumorigenesis. Proc Natl Acad Sci U S A 110:6418-23
Linares, Juan F; Duran, Angeles; Yajima, Tomoko et al. (2013) K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol Cell 51:283-96
Ma, Li; Tao, Yongzhen; Duran, Angeles et al. (2013) Control of nutrient stress-induced metabolic reprogramming by PKC? in tumorigenesis. Cell 152:599-611
Moscat, Jorge; Diaz-Meco, Maria T (2012) p62: a versatile multitasker takes on cancer. Trends Biochem Sci 37:230-6
Diaz-Meco, Maria T; Moscat, Jorge (2012) The atypical PKCs in inflammation: NF-*B and beyond. Immunol Rev 246:154-67
Moscat, Jorge; Diaz-Meco, Maria T (2011) Feedback on fat: p62-mTORC1-autophagy connections. Cell 147:724-7
Linares, Juan F; Amanchy, Ramars; Greis, Kenneth et al. (2011) Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation. Mol Cell Biol 31:105-17
Sengupta, Amitava; Duran, Angeles; Ishikawa, Eri et al. (2011) Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation. Proc Natl Acad Sci U S A 108:9957-62
Moscat, Jorge; Diaz-Meco, Maria T (2011) Fine tuning NF-ýýB: new openings for PKC-ýý. Nat Immunol 12:12-4
Lee, Sang Jun; Pfluger, Paul T; Kim, Ji Young et al. (2010) A functional role for the p62-ERK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep 11:226-32

Showing the most recent 10 out of 18 publications